Boothbay Fund Management’s Connect Biopharma Holdings CNTB Stock Holding History

Boothbay Fund Management’s Portfolio CNTB Stock Details CNTB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.32M	Sell	973,732 -260,850	-21%	-$632K	0.03%	662
2026 Q1	$3.23M	Hold	1,234,582	–	–	0.04%	447
2025 Q4	$3.48M	Buy	+1,234,582	New	+$2.63M	0.05%	414
2023 Q3	–	Sell	-26,867	Closed	-$30.4K	–	1784
2023 Q2	$30.4K	Hold	26,867	–	–	﹤0.01%	1701
2023 Q1	$26.9K	Hold	26,867	–	–	﹤0.01%	2051
2022 Q4	$23.3K	Hold	26,867	–	–	﹤0.01%	1917
2022 Q3	$35K	Sell	26,867 -50,984	-65%	-$61.3K	﹤0.01%	2137
2022 Q2	$68K	Hold	77,851	–	–	﹤0.01%	2046
2022 Q1	$235K	Buy	77,851 +48,167	+162%	+$203K	0.01%	1790
2021 Q4	$153K	Buy	+29,684	New	+$330K	﹤0.01%	1584

Other funds holding CNTB

Ikarian Capital Dallas, Texas $928M AUM 596.14% 1-Year Est. Return

6CM

683 Capital Management New York $2.04B AUM 94.26% 1-Year Est. Return

BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return

Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return

ADAR1 Capital Management Austin, Texas $2.19B AUM 374.99% 1-Year Est. Return

BCM

BML Capital Management Zionsville, Indiana $188M AUM 88.51% 1-Year Est. Return

Silverarc Capital Management Boston, Massachusetts $854M AUM 179.73% 1-Year Est. Return

Richmond Brothers Jackson, Michigan $203M AUM 19.78% 1-Year Est. Return

DMKJ

David M. Knott Jr $183M AUM 73.23% 1-Year Est. Return

Stonepine Capital Management Bend, Oregon $159M AUM 62.27% 1-Year Est. Return

Boothbay Fund Management's CNTB Position: Q2 2026 in Review

Boothbay Fund Management reduced its Connect Biopharma Holdings (CNTB) stake by 21% in Q2 2026, selling an estimated $632K and leaving 973,732 shares worth $2.32M. The position accounts for 0.03% of the portfolio, ranked #662.

Boothbay Fund Management first reported a position in CNTB in Q4 2021 and has held it in 10 quarters since. The position peaked at $3.48M in Q4 2025. 57 funds tracked by Wall St. Rank hold CNTB as of Q2 2026.

Boothbay Fund Management held 973,732 shares of Connect Biopharma Holdings worth $2.32M as of Q2 2026.
Boothbay Fund Management sold 260,850 Connect Biopharma Holdings shares in Q2 2026, an estimated $632K.
Connect Biopharma Holdings made up 0.03% of Boothbay Fund Management's portfolio in Q2 2026, its #662 holding.
Boothbay Fund Management first reported a position in Connect Biopharma Holdings in Q4 2021 and has held it in 10 quarters since.
Boothbay Fund Management's Connect Biopharma Holdings position peaked at $3.48M in Q4 2025.
57 funds tracked by Wall St. Rank held Connect Biopharma Holdings as of Q2 2026.

Based on Boothbay Fund Management's 13F filing for Q2 2026, filed 14 Aug 2026.